首页> 外文期刊>The Annals of applied statistics >DYNAMIC PREDICTION OF DISEASE PROGRESSION FOR LEUKEMIA PATIENTS BY FUNCTIONAL PRINCIPAL COMPONENT ANALYSIS OF LONGITUDINAL EXPRESSION LEVELS OF AN ONCOGENE
【24h】

DYNAMIC PREDICTION OF DISEASE PROGRESSION FOR LEUKEMIA PATIENTS BY FUNCTIONAL PRINCIPAL COMPONENT ANALYSIS OF LONGITUDINAL EXPRESSION LEVELS OF AN ONCOGENE

机译:白血病患者疾病进展的动态预测癌基因纵向表达水平的功能主成分分析

获取原文
获取原文并翻译 | 示例
           

摘要

Patients' biomarker data are repeatedly measured over time during their follow-up visits. Statistical models are needed to predict disease progression on the basis of these longitudinal biomarker data. Such predictions must be conducted on a real-time basis so that at any time a new biomarker measurement is obtained, the prediction can be updated immediately to reflect the patient's latest prognosis and further treatment can be initiated as necessary. This is called dynamic prediction. The challenge is that longitudinal biomarker values fluctuate over time, and their changing patterns vary greatly across patients. In this article, we apply functional principal components analysis (FPCA) to longitudinal biomarker data to extract their features, and use these features as covariates in a Cox proportional hazards model to conduct dynamic predictions. Our flexible approach comprehensively characterizes the trajectory patterns of the longitudinal biomarker data. Simulation studies demonstrate its robust performance for dynamic prediction under various scenarios. The proposed method is applied to dynamically predict the risk of disease progression for patients with chronic myeloid leukemia following their treatments with tyrosine kinase inhibitors. The FPCA method is applied to their longitudinal measurements of BCR-ABL gene expression levels during follow-up visits to obtain the changing patterns over time as predictors.
机译:在随访期间,患者的生物标志物数据会随着时间的推移反复测量。根据这些纵向生物标志物数据,需要统计模型来预测疾病进展。此类预测必须实时进行,以便在任何时候获得新的生物标志物测量,预测可以立即更新,以反映患者的最新预后,并在必要时启动进一步治疗。这叫做动态预测。挑战在于,纵向生物标志物值随时间而波动,其变化模式因患者而异。在本文中,我们将功能主成分分析(FPCA)应用于纵向生物标志物数据以提取其特征,并将这些特征作为Cox比例风险模型中的协变量来进行动态预测。我们灵活的方法全面描述了纵向生物标志物数据的轨迹模式。仿真研究表明,该算法在各种情况下具有良好的动态预测性能。该方法用于动态预测慢性髓系白血病患者在接受酪氨酸激酶抑制剂治疗后疾病进展的风险。在随访期间,FPCA方法应用于BCR-ABL基因表达水平的纵向测量,以获得随时间变化的模式作为预测因子。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号